__timestamp | Bristol-Myers Squibb Company | Jazz Pharmaceuticals plc |
---|---|---|
Wednesday, January 1, 2014 | 15879000000 | 1172875000 |
Thursday, January 1, 2015 | 16560000000 | 1324803000 |
Friday, January 1, 2016 | 19427000000 | 1487973000 |
Sunday, January 1, 2017 | 20776000000 | 1618693000 |
Monday, January 1, 2018 | 22561000000 | 1890922000 |
Tuesday, January 1, 2019 | 26145000000 | 2161761000 |
Wednesday, January 1, 2020 | 42518000000 | 2363567000 |
Friday, January 1, 2021 | 46385000000 | 3094238000 |
Saturday, January 1, 2022 | 46159000000 | 3659374000 |
Sunday, January 1, 2023 | 45006000000 | 3834204000 |
Monday, January 1, 2024 | 48300000000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical industry, revenue growth is a key indicator of a company's success and market influence. Over the past decade, Bristol-Myers Squibb Company and Jazz Pharmaceuticals plc have demonstrated remarkable financial trajectories. From 2014 to 2023, Bristol-Myers Squibb's revenue surged by approximately 183%, peaking in 2021 with a staggering $46.4 billion. This growth reflects strategic acquisitions and a robust product pipeline. Meanwhile, Jazz Pharmaceuticals, though smaller in scale, exhibited a consistent upward trend, with revenues increasing by over 227% during the same period, reaching nearly $3.8 billion in 2023. This growth underscores Jazz's focus on niche markets and innovative therapies. As the pharmaceutical landscape continues to shift, these companies exemplify resilience and adaptability, setting benchmarks for revenue performance in the sector.
Who Generates More Revenue? AbbVie Inc. or Bristol-Myers Squibb Company
Revenue Insights: Merck & Co., Inc. and Bristol-Myers Squibb Company Performance Compared
Bristol-Myers Squibb Company and Gilead Sciences, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: Bristol-Myers Squibb Company vs United Therapeutics Corporation
Breaking Down Revenue Trends: Bristol-Myers Squibb Company vs Exelixis, Inc.
Bristol-Myers Squibb Company vs Telix Pharmaceuticals Limited: Annual Revenue Growth Compared
Bristol-Myers Squibb Company vs HUTCHMED (China) Limited: Examining Key Revenue Metrics
Bristol-Myers Squibb Company and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Bristol-Myers Squibb Company vs Taro Pharmaceutical Industries Ltd.
Vertex Pharmaceuticals Incorporated or Jazz Pharmaceuticals plc: Who Leads in Yearly Revenue?
Revenue Showdown: Jazz Pharmaceuticals plc vs Pharming Group N.V.
Comparing Revenue Performance: Jazz Pharmaceuticals plc or Galapagos NV?